Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Cyclophosphamide for interstitial lung disease-associated acute respiratory failure: mortality, clinical response and radiological characteristics

Fig. 3

P/F ratio and dynamic compliance before and after cyclophosphamide therapy. o survivors; x non-survivors. a Case 7 was not shown: ECMO, therefore no realistic P/F ratio. b Case 9 was not shown: patient was extubated after cyclophosphamide treatment; therefore, Cdyn after cyclophosphamide was not available. cdyn: dynamic compliance; CYC: cyclophosphamide; P/F ratio: PaO2/FiO2-ratio

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us